Previous close | 215.50 |
Open | 214.75 |
Bid | 214.67 x 500 |
Ask | 215.08 x 100 |
Day's range | 213.58 - 217.73 |
52-week range | 189.44 - 319.76 |
Volume | |
Avg. volume | 1,299,691 |
Market cap | 31.277B |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | 26.85 |
EPS (TTM) | 8.00 |
Earnings date | 23 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 284.76 |
Eli Lilly reported strong sales of weight-loss drug Zepbound in the first quarter. Is Eli Lilly stock a buy?
In this article, we discuss the 10 most promising stocks to buy before they take off. To skip the detailed analysis of the current earnings week, go directly to the 5 Most Promising Stocks to Buy Before They Take Off. Meta Grows Revenue by 27% in Q1, Provides Weak Outlook for FY ’24 The market […]
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...